当前位置: 首页 > 期刊 > 《中国医学创新》 > 2013年第4期
编号:12357544
老年2型糖尿病患者超敏C反应蛋白与动脉硬化的相关性研究(2)
http://www.100md.com 2013年2月5日 《中国医学创新》 2013年第4期
     参考文献

    [1] Ziegler D.Type 2 diabetes as an inflammatory cardiovascular Disorder[J].Curr Mol Med,2005,5(3):309-322.

    [2] Thorand B,Lowesl H,Schneider A,et al.C-reactive protein as a predictorfor incident diabetes mellitus among middle-aged men:results from MONICA Augsburg cohort study,1984-1998[J].Arch Intern Med,2003,163(1):93-99.

    [3] Rodriguez Moran M,Guerrero Romero F.Elevated concentrations of C-reactive protein in subjectswith type 2 diabetes mellitus are moderately influenced by glycaemiccontrol[J].J Endocrinol Invest,2003,26(3):216-221.

    [4] Verma S,Lis H ,Badiwala M V,et al.Endothelin Antagoniam and interleukin-6 inhibition attenuate the proatherogenic effect s of C-reactive protein[J].Circulation,2002,105(16):1890-1896.

    [5] 龙艳,苏轲,于健,等.2型糖尿病患者超敏C反应蛋白及肿瘤坏死因子α与微血管并发症的关系[J].中国临床康复,2005,9(3):120-122.

    [6] Venugopal S K,Devaraj S,Yuhanna I,et al.Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells[J].Circulation,2002,106(12):1439-1441.

    [7] Bloomgarden Z T.Inflammation and insulin resistance[J].Diabetes Care,2003,26(6):1922-1926.

    [8] Lobner K,Knopff A,Baumgarten A,et al.Predictors of postpartum diabetes in women with gestational diabetes mellitus[J].Diabetes,2006,55(3):792-797.

    (收稿日期:2012-09-18) (本文编辑:连胜利), 百拇医药(符琴 王成)
上一页1 2